Suppr超能文献

胃内注射肉毒毒素 A 用于减肥治疗。

Gastric Botulinum Toxin-A Application for Weight Loss Therapy.

机构信息

Türkçapar Bariatrics, Obesity Center, İstanbul, Turkey;Department of Health Sciences, Nişantaşı University, İstanbul, Turkey.

Türkçapar Bariatrics, Obesity Center, İstanbul, Turkey.

出版信息

Turk J Gastroenterol. 2021 Jan;32(1):66-69. doi: 10.5152/tjg.2020.20076.

Abstract

BACKGROUND/AIMS: The aim of this study is to share the results of gastric botulinum toxin (BTX) application in individuals who are overweight or type 1 obese without comorbidity.

MATERIALS AND METHODS

In this study, 13 patients were included who were enrolled for gastric BTX application for the first time. A total of 300 U of BTX-A (Allergan Botox ®1 vial 100 U) was diluted with 8 mL of 0.9% NaCl saline, and antrum (100 U to 8 spots), corpus (100 U to 8 spots), and fundus (100 U to 8 spots) regions were injected intramuscularly. Patients were given a 1200-calorie low-carb diet and this was followed for 6 months.

RESULTS

Gastric BTX application was applied to 13 patients with a mean age of 40.9 ± 5.2 (85% female), a mean body mass index (BMI) of 28.41 ± 1.4 kg/m2 (26-31.6) and a mean excess weight of 10.1 ± 3.6 kg. As a result of the 6-month follow-up, only four patients (30.8%) were able to lose more than 50% of their excess weight (6-15 kg). Six patients (46.2%) could not lose any weight. There was an average decrease of 3.3 kg in the weight of patients before and after BTX application (P = .03). A mean decrease of BMI was detected, 1.17 kg/m2 (P = .032).

CONCLUSION

It was concluded that the application of gastric BTX for weight loss does not provide effective results.

摘要

背景/目的:本研究旨在分享胃内肉毒毒素(BTX)应用于无合并症的超重或 1 型肥胖个体的结果。

材料和方法

本研究纳入了首次接受胃 BTX 应用的 13 例患者。将 1 瓶 100U 的 BTX-A(Allergan Botox ®1 支 100U)稀释至 8ml 0.9%生理盐水,在胃窦(100U 注射 8 个部位)、胃体(100U 注射 8 个部位)和胃底(100U 注射 8 个部位)区域进行肌内注射。患者给予 1200 卡路里低碳水化合物饮食,并持续 6 个月。

结果

胃 BTX 应用于 13 例患者,平均年龄为 40.9 ± 5.2(85%为女性),平均体重指数(BMI)为 28.41 ± 1.4kg/m2(26-31.6),平均超重 10.1 ± 3.6kg。6 个月随访时,仅有 4 例患者(30.8%)能减轻超过 50%的超重(6-15kg)。6 例患者(46.2%)体重无变化。BTX 应用前后患者体重平均减轻 3.3kg(P=0.03)。检测到 BMI 平均降低 1.17kg/m2(P=0.032)。

结论

胃 BTX 应用于减肥效果不佳。

相似文献

1
Gastric Botulinum Toxin-A Application for Weight Loss Therapy.
Turk J Gastroenterol. 2021 Jan;32(1):66-69. doi: 10.5152/tjg.2020.20076.
3
Intragastric injection of botulinum toxin A for the treatment of obesity.
Obes Surg. 2007 Jun;17(6):732-6. doi: 10.1007/s11695-007-9135-x.
5
Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study.
Int J Obes (Lond). 2007 Apr;31(4):707-12. doi: 10.1038/sj.ijo.0803451. Epub 2006 Sep 26.
7
Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study.
Aliment Pharmacol Ther. 2006 Mar 1;23(5):675-80. doi: 10.1111/j.1365-2036.2006.02773.x.
9
Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study.
Obes Surg. 2008 Apr;18(4):401-7. doi: 10.1007/s11695-008-9442-x. Epub 2008 Feb 20.
10

本文引用的文献

1
Obesity Treatment with Botulinum Toxin-A Is Not Effective: a Systematic Review and Meta-Analysis.
Obes Surg. 2017 Oct;27(10):2716-2723. doi: 10.1007/s11695-017-2857-5.
2
Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014.
Obes Surg. 2017 Sep;27(9):2279-2289. doi: 10.1007/s11695-017-2666-x.
3
Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression.
Gastrointest Endosc. 2015 May;81(5):1141-9.e1-7. doi: 10.1016/j.gie.2014.12.025. Epub 2015 Mar 9.
4
Botulinum toxins: mechanisms of action, antinociception and clinical applications.
Toxicology. 2013 Apr 5;306:124-46. doi: 10.1016/j.tox.2013.02.006. Epub 2013 Feb 19.
5
Botulinum neurotoxins: mechanism of action.
Toxicon. 2013 Jun 1;67:87-93. doi: 10.1016/j.toxicon.2012.11.011. Epub 2012 Nov 29.
6
Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight.
Clin Gastroenterol Hepatol. 2013 Feb;11(2):145-50.e1. doi: 10.1016/j.cgh.2012.09.029. Epub 2012 Oct 9.
8
Endoscopic treatment of obesity.
Can J Gastroenterol. 2011 Nov;25(11):627-33. doi: 10.1155/2011/174163.
10
Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study.
Gastroenterol Clin Biol. 2005 Aug-Sep;29(8-9):789-91. doi: 10.1016/s0399-8320(05)86349-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验